PKM2 MEDIATED EMT INDUCTION BY STEROID SULFATASE IN HUMAN PROSTATE CANCER CELLS
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Shin, Sangyun | - |
dc.contributor.author | Kwon, Yeo-Jung | - |
dc.contributor.author | Ye, Dong-Jin | - |
dc.contributor.author | Baek, Hyoung-Seok | - |
dc.contributor.author | Chun, Young-Jin | - |
dc.date.accessioned | 2022-04-06T02:40:09Z | - |
dc.date.available | 2022-04-06T02:40:09Z | - |
dc.date.issued | 2017-01 | - |
dc.identifier.issn | 1347-4367 | - |
dc.identifier.issn | 1880-0920 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/55900 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | JAPANESE SOC STUDY XENOBIOTICS | - |
dc.title | PKM2 MEDIATED EMT INDUCTION BY STEROID SULFATASE IN HUMAN PROSTATE CANCER CELLS | - |
dc.type | Article | - |
dc.identifier.doi | 10.1016/j.dmpk.2016.10.242 | - |
dc.identifier.bibliographicCitation | DRUG METABOLISM AND PHARMACOKINETICS, v.32, no.1, pp S60 - S60 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.wosid | 000397013800199 | - |
dc.citation.endPage | S60 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | S60 | - |
dc.citation.title | DRUG METABOLISM AND PHARMACOKINETICS | - |
dc.citation.volume | 32 | - |
dc.type.docType | Meeting Abstract | - |
dc.publisher.location | 일본 | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.